Comprehensive healthcare analytics solutions grounded in international best practices and tailored to your organization's needs.
Health Technology Assessment is the systematic evaluation of properties, effects, and impacts of health technologies and interventions. At Pharma Org, we conduct rigorous HTA analyses that help health authorities and pharmaceutical companies make informed decisions about the adoption, pricing, and reimbursement of new treatments, medical devices, and diagnostic tools.
Our HTA services are aligned with internationally recognized frameworks including ISPOR good practices, NICE reference case methodology, and WHO-CHOICE guidelines. We assess the clinical effectiveness, safety profile, cost-effectiveness, budget impact, and broader societal implications of health technologies to provide a comprehensive evidence base for decision-making.
Whether you are preparing a dossier for a national HTA body, seeking to understand the comparative effectiveness of competing therapies, or developing a reimbursement strategy for a new market, our team provides the analytical rigor and strategic insight needed to succeed.
Pharmacoeconomic modeling is at the core of modern healthcare decision-making. Our team develops sophisticated economic models that quantify the value of pharmaceutical interventions, enabling stakeholders to compare costs and outcomes across treatment options and make resource allocation decisions grounded in robust evidence.
We specialize in building decision-analytic models tailored to specific therapeutic areas, patient populations, and healthcare settings. Our models are developed following ISPOR-SMDM best practices for modeling and are designed to be transparent, reproducible, and adaptable to different payer perspectives.
Our economic evaluations consider direct medical costs, indirect costs (such as productivity losses), and health outcomes measured in quality-adjusted life years (QALYs) or other clinically relevant endpoints. We conduct extensive sensitivity analyses — including deterministic, probabilistic, and scenario analyses — to characterize uncertainty and provide decision-makers with a complete picture of the value proposition.
In today's data-rich healthcare environment, the ability to extract meaningful insights from complex datasets is essential. Our statistical consulting services span the full spectrum of healthcare research — from study design and protocol development through data collection, analysis, and interpretation.
Our team has deep expertise in the statistical methods most relevant to healthcare and pharmaceutical research. We work with clinical trial data, observational studies, patient registries, claims databases, and electronic health records to generate the evidence needed for regulatory submissions, health technology assessments, and commercial strategy development.
We are particularly experienced in generating real-world evidence (RWE) from diverse data sources, conducting indirect treatment comparisons when head-to-head trial data is unavailable, and performing population-level analyses that inform public health policy.
Navigating the complex landscape of pharmaceutical policy, market access, and regulatory affairs requires deep expertise and strategic vision. Our policy consultancy services help organizations understand and influence healthcare policy at national and regional levels, ensuring that evidence-based approaches are embedded in decision-making frameworks.
We work closely with pharmaceutical companies to develop market access strategies that align with local regulatory requirements and payer expectations. Our team has direct experience with the Egyptian Drug Authority and health ministries across the region, giving us unique insight into the regulatory and policy environment that shapes pharmaceutical markets in the Middle East and North Africa.
Our policy advisory work extends to supporting governments and health authorities in developing HTA frameworks, essential medicines lists, and pharmaceutical pricing policies.
Contact us to discuss how our services can support your healthcare decision-making and market access objectives.
Request Consultation →